Kala Bio Announces Topline Results From Chase Phase 2B Clinical Trial

ReutersSep 29, 2025 12:11 PM

View all comments（0）



Sept 29 (Reuters) - KALA BIO Inc KALA.O:

KALA BIO ANNOUNCES TOPLINE RESULTS FROM CHASE PHASE 2B CLINICAL TRIAL EVALUATING KPI-012 FOR THE TREATMENT OF PERSISTENT CORNEAL EPITHELIAL DEFECT (PCED) DID NOT MEET PRIMARY ENDPOINT
KALA BIO INC - CHASE TRIAL FAILED TO ACHIEVE STATISTICAL SIGNIFICANCE FOR SECONDARY ENDPOINTS
KALA BIO INC - KPI-012 TRIAL DID NOT MEET PRIMARY ENDPOINT
KALA BIO INC - PLANS WORKFORCE REDUCTION AND COST-SAVING MEASURES
KALA BIO INC - TO CEASE KPI-012 DEVELOPMENT, EVALUATE STRATEGIC OPTIONS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Samsung’s Largest Strike in History: Can SK Hynix and Micron Sit Back and Reap the Benefits?

TradingKey - On May 21, 61,000 union members at Samsung Electronics will launch an 18-day general strike, following a 93.1% approval vote. Government mediation between labor and management has collapsed.

Japan and South Korea Stocks Open Lower, Samsung Strike Storm and Higher-Than-Expected Inflation Disrupt Markets

TradingKey - On May 13, the Nikkei 225 Index opened 0.5% lower, while South Korea’s KOSPI Index opened down 1.7% before losses further widened to 3%.

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

TradingKey - Despite the ongoing US-Iran war and the continued closure of the Strait of Hormuz, copper prices maintain a solid floor. This Monday, LME (London Metal Exchange) three-month copper reached $13,637 per tonne at one point, marking its highest level since January 29. On the same day, LME three-month copper recorded a peak closing price of $13,952/tonne, with intraday prices briefly rising above $14,500/tonne.

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.

SK Hynix Surges 15% to New High: HBM Shortage Until 2028, How Much Longer Can AI Memory King Rise?

TradingKey - During the Asian trading session on May 11, SK Hynix shares rose by more than 15% at one point, hitting an all-time intraday high of 1.949 million KRW, with its market capitalization surpassing $900 billion. The year-to-date cumulative gain is approximately 197.03%, with the share price nearly tripling.

Featured Tools